[{"Assets_0_Q1_USD":9372696000.0,"EarningsPerShareBasic_1_Q1_USD":4.44,"EarningsPerShareDiluted_1_Q1_USD":4.16,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":618743000.0,"NetIncomeLossConverted_1_Q1_USD":477980000.0,"RevenuesConverted_1_Q1_USD":987909000.0,"StockholdersEquity_0_Q1_USD":6567644000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":114906000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":107648000.0,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS INC","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20180503"}]